Pharma channel feed

Drug prices in TV ads again? Sen­a­tors take an­oth­er swing with ex­pe­dit­ed bill

Last year
Marketing

No­vo Nordisk ramps up le­gal case against com­pound­ing phar­ma­cies sell­ing 'mis­brand­ed' semaglu­tide

Last year
Law

FDA ships Form 483 to gener­ic drug gi­ant Dr. Red­dy’s due to equip­ment is­sues, oth­er ob­ser­va­tions

Last year
FDA+
Manufacturing

GSK is win­ning 70% of the RSV mar­ket, while Pfiz­er's launch has left it ‘dis­ap­point­ed’ so far

Last year

Up­dat­ed: Ab­b­Vie to ac­quire Im­muno­Gen for $10B in ban­ner year for AD­Cs

Last year
Deals

Luke Miels sheds light on GSK in­ter­nal changes, ‘very busy’ BD scene

Last year

Clin­i­cians say ben­e­fits of CAR-T con­tin­ue to out­weigh risk of T-cell ma­lig­nan­cies

Last year
Cell/Gene Tx
FDA+

Ab­b­Vie is gun­ning for ac­cel­er­at­ed ap­proval of an­ti­body-drug con­ju­gate af­ter pos­i­tive PhII da­ta

Last year
R&D

FDA opens re­view of CAR-T safe­ty af­ter iden­ti­fy­ing 19 cas­es of post-treat­ment blood can­cer

Last year
Cell/Gene Tx
FDA+

Bio­Marin lands three-year deal for Ger­man cov­er­age of gene ther­a­py at $900K per pa­tient

Last year
Cell/Gene Tx

Mar­ket­ingRx roundup: Pfiz­er adds hol­i­day twist to Covid boost­er ef­fort; No­vavax signs up for sports

Last year
Marketing

No­var­tis ex­ecs high­light progress of slim­mer pipeline af­ter San­doz spin­off

Last year
R&D

Take­da aligns with lead­ing rare dis­ease group for calls to ac­tion around health eq­ui­ty di­ag­noses

Last year
Marketing

Mer­ck stokes pneu­mo­coc­cal ri­val­ry with Pfiz­er, re­veal­ing up­dat­ed 21-va­lent vac­cine da­ta

Last year
R&D

Who cares about phar­ma ESG ef­forts? Pa­tients and pa­tient groups do — and they want more, sur­vey finds

Last year
Marketing

Bris­tol My­ers bets $100M on Avid­i­ty's RNA ther­a­pies for car­dio­vas­cu­lar dis­eases

Last year
Deals
R&D

Spring­Works Ther­a­peu­tics ready to launch new­ly-ap­proved desmoid tu­mor treat­ment af­ter three-month de­lay

Last year
FDA+

Mar­ius aims to shake up typ­i­cal think­ing about testos­terone in new cam­paign

Last year
Marketing

Lo­cal Vir­ginia gov­ern­ments add to in­sulin law­suits against Eli Lil­ly, No­vo Nordisk, Sanofi, oth­ers

Last year
Law

Sh­iono­gi brings gen­er­a­tive AI to med­ical con­fer­ences with 'War­rior' por­trait cam­paign

Last year
AI
Marketing

US gov­ern­ment turns to more do­mes­tic phar­ma man­u­fac­tur­ing to im­prove sup­ply chain re­silience 

Last year
Manufacturing

Sanofi, Re­gen­eron say Dupix­ent suc­ceeds in an­oth­er late-stage COPD study, set­ting up fil­ing for FDA ap­proval

Last year
R&D

Ab­b­Vie sues five gener­ic com­pa­nies over po­ten­tial Rin­voq com­peti­tors

Last year
Law

US In­ter­na­tion­al Trade Com­mis­sion takes on Eli Lil­ly's tirzepatide case

Last year
Law
First page Previous page 87888990919293 Next page Last page
A service from the Financial Times